Comments to FDA: Labeling Requirements for OTC Human Drugs

Share page:
Docket Number:
1998 N-0337C

FDA issued a proposed rule on labeling requirements for OTC human drugs. The announcement proposed a definition for “convenience-size” OTC drug packages as well as the option of alternative labeling requirements for these products. CHPA welcomes the opportunity to comment on the proposed rule changes.

Related Posts

CHPA Welcomes New Board Members at June Meeting